FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Approves Bayer Mirena sNDA

FDA approves a Bayer sNDA for its Mirena intrauterine system for extended use of up to eight years as a contraceptive.

latest-news-card-1
Human Drugs

Astellas Files NDA for Vasomotor Symptom Therapy

FDA accepts for priority review an Astellas Pharma NDA for fezolinetant, a nonhormonal compound for treating moderate to severe vasomotor symptoms (ho...

latest-news-card-1
Medical Devices

FDA Warning on Retractable Needles

FDA warns about the potential for needle stick injuries from recently recalled Haiou Needle Retractable Safety 1 mL syringe with 23G 1-inch needle and...

Biologics

Fall Covid Boosters on Fast Track with Mouse Data

FDA is permitting Covid-19 vaccine makers to submit mouse data to expedite authorization of their omicron-protecting vaccine boosters, a move some see...

latest-news-card-1
Federal Register

Final Rule on OTC Hearing Aids

Federal Register final rule: FDA establishes a regulatory category for over-the-counter hearing aids and making related amendments to update the regul...

latest-news-card-1
Medical Devices

Respironics Ventilator MDRs Increase

FDA says it has received 168 reports of deaths in more than 69,000 medical device reports associated with PE-PUR foam degradation in Philips Respironi...

latest-news-card-1
Medical Devices

Preceptis Device Cleared for Ear Tube Procedures

FDA clears a Preceptis Medical 510(k) for expanded indications for its Hummingbird Tympanostomy Tube System for office-based pediatric ear tube proced...

latest-news-card-1
Biologics

Gene Therapy OKd for Blood Disorder

FDA approves the first cell-based gene therapy for treating adult and pediatric patients with beta-thalassemia who require regular red blood cell tran...

latest-news-card-1
Medical Devices

FDA Cybersecurity 2022 Guidance Explained

Attorney Brynn Stanley outlines provisions in a 2022 FDA draft cybersecurity guidance and how they differ from the 2018 draft it replaced.

latest-news-card-1
Biologics

Brainstorm to File BLA for Lou Gehrigs Disease

Brainstorm Cell Therapeutics says it will submit a BLA for it NurOwn stem cell therapy for treating amyotrophic lateral sclerosis.